Eric T Lofgren1, Stephen R Cole, David J Weber, Deverick J Anderson, Rebekah W Moehring. 1. From the aDepartment of Epidemiology, UNC Gillings School of Global Public Health, Chapel Hill, NC; bDepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC; and cDuke Infection Control Outreach Network, Duke University School of Medicine, Durham, NC.
Abstract
BACKGROUND: Clostridium difficile is a health care-associated infection of increasing importance. The purpose of this study was to estimate the time until death from any cause and time until release among patients with C. difficile, comparing the burden of those in the intensive care unit (ICU) with those in the general hospital population. METHODS: A parametric mixture model was used to estimate event times, as well as the case-fatality ratio in ICU and non-ICU patients within a cohort of 609 adult incident cases of C. difficile in the Southeastern United States between 1 July 2009 and 31 December 2010. RESULTS: ICU patients had twice the median time to death (relative time = 1.97 [95% confidence interval (CI) = 0.96-4.01]) and nearly twice the median time to release (1.88 [1.40-2.51]) compared with non-ICU patients. ICU patients also experienced 3.4 times the odds of mortality (95% CI = 1.8-6.2). Cause-specific competing risks analysis underestimated the relative survival time until death (0.65 [0.36-1.17]) compared with the mixture model. CONCLUSIONS: Patients with C. difficile in the ICU experienced higher mortality and longer lengths of stay within the hospital. ICU patients with C. difficile infection represent a population in need of particular attention, both to prevent adverse patient outcomes and to minimize transmission of C. difficile to other hospitalized patients.
BACKGROUND: Clostridium difficile is a health care-associated infection of increasing importance. The purpose of this study was to estimate the time until death from any cause and time until release among patients with C. difficile, comparing the burden of those in the intensive care unit (ICU) with those in the general hospital population. METHODS: A parametric mixture model was used to estimate event times, as well as the case-fatality ratio in ICU and non-ICU patients within a cohort of 609 adult incident cases of C. difficile in the Southeastern United States between 1 July 2009 and 31 December 2010. RESULTS: ICU patients had twice the median time to death (relative time = 1.97 [95% confidence interval (CI) = 0.96-4.01]) and nearly twice the median time to release (1.88 [1.40-2.51]) compared with non-ICU patients. ICU patients also experienced 3.4 times the odds of mortality (95% CI = 1.8-6.2). Cause-specific competing risks analysis underestimated the relative survival time until death (0.65 [0.36-1.17]) compared with the mixture model. CONCLUSIONS: Patients with C. difficile in the ICU experienced higher mortality and longer lengths of stay within the hospital. ICU patients with C. difficile infection represent a population in need of particular attention, both to prevent adverse patient outcomes and to minimize transmission of C. difficile to other hospitalized patients.
Authors: Stephen R Cole; Rui Li; Kathryn Anastos; Roger Detels; Mary Young; Joan S Chmiel; Alvaro Muñoz Journal: Stat Med Date: 2004-11-15 Impact factor: 2.373
Authors: Deverick J Anderson; Becky A Miller; Luke F Chen; Linda H Adcock; Evelyn Cook; A Lynn Cromer; Susan Louis; Paul A Thacker; Daniel J Sexton Journal: Infect Control Hosp Epidemiol Date: 2011-04 Impact factor: 3.254
Authors: L Clifford McDonald; Bruno Coignard; Erik Dubberke; Xiaoyan Song; Teresa Horan; Preeta K Kutty Journal: Infect Control Hosp Epidemiol Date: 2007-01-25 Impact factor: 3.254
Authors: A C Ghani; C A Donnelly; D R Cox; J T Griffin; C Fraser; T H Lam; L M Ho; W S Chan; R M Anderson; A J Hedley; G M Leung Journal: Am J Epidemiol Date: 2005-08-02 Impact factor: 4.897
Authors: Irene K Louh; William G Greendyke; Emilia A Hermann; Karina W Davidson; Louise Falzon; David K Vawdrey; Jonathan A Shaffer; David P Calfee; E Yoko Furuya; Henry H Ting Journal: Infect Control Hosp Epidemiol Date: 2017-04 Impact factor: 3.254
Authors: D Alexander Perry; Daniel Shirley; Dejan Micic; Pratish C Patel; Rosemary Putler; Anitha Menon; Vincent B Young; Krishna Rao Journal: Clin Infect Dis Date: 2022-06-10 Impact factor: 20.999
Authors: David M Faleck; Hojjat Salmasian; E Yoko Furuya; Elaine L Larson; Julian A Abrams; Daniel E Freedberg Journal: Am J Gastroenterol Date: 2016-08-30 Impact factor: 10.864
Authors: Eric M Fountain; Maggie C Moses; Lawrence P Park; Christopher W Woods; Gowthami M Arepally Journal: J Thromb Thrombolysis Date: 2017-01 Impact factor: 2.300
Authors: Theodore R Pak; Kieran I Chacko; Timothy O'Donnell; Shirish S Huprikar; Harm van Bakel; Andrew Kasarskis; Erick R Scott Journal: Infect Control Hosp Epidemiol Date: 2017-11-06 Impact factor: 3.254
Authors: F Eun-Hyung Lee; John L Daiss; Natalie S Haddad; Sophia Nozick; Geena Kim; Shant Ohanian; Colleen S Kraft; Paulina A Rebolledo; Yun Wang; Hao Wu; Adam Bressler; Sang Nguyet Thi Le; Merin Kuruvilla; Martin C Runnstrom; Richard P Ramonell; L Edward Cannon Journal: J Clin Microbiol Date: 2022-03-16 Impact factor: 11.677